CD274 and neoplasm: Nevertheless, effective reduction of PD-L1 expression in tumor cells appears to anti-tumor immunity and reduce tumor drug resistance, as shown in a study whereby PD-L1 protein was overexpressed in cisplatin-resistant human non-small cell lung cancer (NSCLC) cell line A549/DDP.